Africa: CDC invests in Adjuvant Capital’s venture fund

CDC Group has invested in a US$300m fund from Adjuvant Capital focused on accelerating the development of medical innovations for public health challenges. Launched in 2019, Adjuvant’s debut fund will support promising new technologies for indications that the venture capital industry has, what is calls, “largely ignored”. “Access to healthcare for all is a fundamental…